Abselion has announced the appointment of Dale Gordon as Chair of the Board of Directors. His appointment strengthens ...

Of all the impacts that Donald Trump has had on America’s relationship with the rest of the world, arguably the most material ...

Indeed, from treatments that were once the stuff of science fiction to everyday products that have quietly transformed public ...

For much of modern medicine, healthcare systems have been structured around treating disease once it becomes clinically ...

Structures change or revert, acronyms multiply and every incoming government promises transformation while discovering that ...

Kenneth Hobby, President of Cure SMA, said: “Nearly ten years ago, the approval of Spinraza marked a turning point in SMA ...

Viridian Therapeutics has announced encouraging topline results from its REVEAL‑1 phase 3 clinical trial evaluating ...

This month’s edition reimagines the NHS dichotomy as a dystopian game of Tetris - we investigate which parties might finally ...

Cure Parkinson’s has announced the formation of a new evaluation panel to review applications submitted to its recent £2 ...

Announcing the approval, UCB said Kygevvi is a 2g/2g powder for oral solution and represents the first therapy available in the European Union beyond supportive care. The company noted that TK2d ...

Positive high‑level results from the phase 3 OBERON and TITANIA trials indicate that tozorakimab achieved statistically significant and clinically meaningful reductions in the a ...

Johnson & Johnson has announced a landmark regulatory decision that will allow people living with multiple myeloma to administer the subcutaneous formulation of daratumumab themse ...